| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE HYDROCHLORIDE | 16 |
| 1 | GEMCITABINE | 13 |
| 2 | TACROLIMUS | 13 |
| 3 | FLUOROURACIL | 12 |
| 4 | FLUOROURACIL CREAM, 0.5% | 12 |
| 5 | BEVACIZUMAB | 11 |
| 6 | OXALIPLATIN | 11 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 8 | TACROLIMUS OINTMENT 0.1% | 11 |
| 9 | PREDNISONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORITAVANCIN DIPHOSPHATE | 1 | 0.0034 |
| 1 | LUMASIRAN | 1 | 0.0026 |
| 2 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 3 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 4 | MINERAL OIL | 1 | 0.0007 |
| 5 | METHYLNALTREXONE BROMIDE | 1 | 0.0007 |
| 6 | TESTOSTERONE ENANTHATE | 1 | 0.0006 |
| 7 | TALAZOPARIB | 1 | 0.0005 |
| 8 | CEFOTAXIME INJECTION | 2 | 0.0005 |
| 9 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 3 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 4 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 6 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 18 | 0.0001 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |